ADIPOQ and metabolic disease: Certain metabolic diseases, such as type 1 diabetes (Maahs et al., 2007; Leth et al., 2008) and IR antibody-induced type B insulin resistance (Semple et al., 2007), exhibit high plasma concentrations of adiponectin.